Andelyn Biosciences, Inc. – FDA Inspection, May 30, 2025

Record Details

This FDA Inspection record concerns Andelyn Biosciences, Inc., with an inspection on May 30, 2025, issued by the Cincinnati District Office, covering biologics.

Company: Andelyn Biosciences, Inc.
Inspection Date: May 30, 2025
Product Type: Biologics
Office: Cincinnati District Office
People: Gregory Stone
Holly Brevig (Investigator)
Jacob L. Bitterman (Issuing Officer)
Mark L. Baum
Susan S. Butler (Issuing Officer)

View Company Profile

ID · ebee63c4-54d3-4630-8c2f-c7f06c619541

Inspection Facts

Inspection number: 1273194
FDA center: Biologics
Outcome: Form 483 issued, view the record

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Andelyn Biosciences, Inc.

FDA Inspection

Andelyn Biosciences, Inc.May 30, 2025

Andelyn Biosciences, Inc. – FDA Inspection, May 30, 2025

Record Details

This FDA Inspection record concerns Andelyn Biosciences, Inc., with an inspection on May 30, 2025, issued by the Cincinnati District Office, covering biologics.